Prevention of marrow graft rejection without induction of graft-versus- host disease by a cytotoxic t-cell clone that recognizes recipient alloantigens

Blood

Volumn 91, Issue 11, 1998, Pages 4038-4044

  Kusunoki, Yoichiro ^b   Chen, Wei ^b   Martin, Paul J ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN;

ANIMAL CELL; ANTIGEN RECOGNITION; ARTICLE; BONE MARROW TRANSPLANTATION; CELL POPULATION; CELL SURVIVAL; CYTOTOXIC T LYMPHOCYTE; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; KILLER CELL; LYMPHOCYTE COUNT; MACROPHAGE ACTIVATION; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; TISSUE INJURY;

EID: 0032100450     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.11.4038.411a11_4038_4044     Document Type: Article

References (42)

1. Martin PJ, Kernan NA: T-cell depletion for GVHD prevention in humans, in Ferrara JLM, Deeg HJ, Burakoff SJ (eds): Graft-vs.-Host Disease, New York, NY, Marcel Dekker, Inc, 1997, p 615
2. Martin PJ: Donor CD8 cells prevent allogeneic marrow graft rejection in mice: Potential implications for marrow transplantation in humans. J Exp Med 178:703, 1993
3. Martin PJ: Prevention of allogeneic marrow graft rejection by donor T cells that do not recognize recipient alloantigens: Potential role of a veto mechanism. Blood 88:962, 1996
4. Nestel F, Kichian K, You-Ten K, Desbarats J, Price K, Lapp WS, Ponka P, Seemayer TA: The role of endotoxin in the pathogenesis of acute grait-versus-host disease, in Ferrara JLM, Deeg HJ, Burakoff SJ (eds): Graft-vs.-Host Disease, New York, NY, Marcel Dekker, Inc, 1997,p 501
5. Hoffman RA, Langrehr JM, Wren SM, Dull KE, Ildstad ST, McCarthy SA, Simmons RL: Characterization of the immunosuppressive effects of nitric oxide during grait-versus-host disease. J Immunol 151:1508, 1993
6. Falzarano G, Krenger W, Snyder KM, Delmonte, J Jr, Karandikar M, Ferrara JLM: Suppression of B-cell proliferation to lipopolysaccharide is mediated through induction of the nitric oxide pathway by tumor necrosis factor-α in mice with acute graft-versus-host disease. Blood 87:2853, 1996
7. Krenger W, Falzarano G, Delmonte J Jr, Snyder KM, Byon JCH, Ferrara JLM: Interferon-γ suppresses T cell proliferation to mitogen via the nitric oxide pathway during experimental acute graft-versus-host disease. Blood 88:1113, 1996
8. Braun MY, Lowin B, French L, Acha-Orbea H, Tschopp J: Cytotoxic T cells deficient in both functional Fas ligand and perform show residual cytolytic activity yet lose their capacity to induce lethal acute graft-versus-host disease. J Exp Med 183:657, 1996
9. Baker MB, Altman NH, Podack ER, Levy RB: The role of cell-mediated cytotoxicity in acute GVHD after MHC-matched allogeneic bone marrow transplantation in mice. J Exp Med 183:2645, 1996
10. Baker MB, Riley RL, Podack ER, Levy RB. GVHD-associated lymphoid hypoplasia and B cell dysfunction is dependent upon donor T cell-mediated Fas-ligand function, but not perform function. Proc Natl Acad Sci USA 94:1366, 1997
11. Schwarzinger I, Raff RF, Flowers MED, Niederwieser D, Graham T, Shulman H, Appelbaum FR, Schuening F, Storb R: Recipient-specific donor cytotoxic T lymphocytes enhance engraftment of unrelated, DLA non-identical canine marrow. Bone Marrow Transplant 13:303, 1994
12. Leo O, Foo M, Sachs DH, Samelson LE, Bluestone JA: Identification of a monoclonal antibody specific for a murine T3 polypeptide. Proc Natl Acad Sci USA 84:1374, 1987
13. Kubo RT, Born W, Kappler JW, Marrack P, Pigeon M: Characterization of a monoclonal antibody which detects all murine αβ T cell receptors. J Immunol 142:2736. 1989
14. Goodman T, LeFrancois L: Intraepithelial lymphocytes: Anatomical site, not T cell receptor form, dictates phenotype and function. J Exp Med 170:1569, 1989
15. Wilde DB, Marrack P, Kapler J, Dialynas DP, Fitch FW: Evidence implicating L3T4 in class II MHC antigen reactivity: Monoclonal antibody GK1.5 (anti-L3T4a) blocks class II MHC antigen-specific proliferation, release of lymphokines, and binding by cloned murine helper T lymphocyte lines. J Immunol 131:2178, 1983
16. Sarmiento M, Glasebrook AL, Fitch FW: IgG or IgM monoclonal antibodies reactive with different determinants on the molecular complex bearing LYT2 antigen block T cell-mediated cytolysis in the absence of complement. J Immunol 125:2665, 1980
17. Lesley J, Trowbridge IS: Genetic characterization of a polymorphic murine cell-surface glycoprotein. Immunogenetics 15:313, 1982
18. Gallatin WM, Weissman IL, Butcher EC: A cell-surface molecule involved in organ-specific homing of lymphocytes. Nature 304:30, 1983
19. Ledbetter JA, Herzenberg LA: Xenogeneic monoclonal antibodies to mouse lymphoid differentiation antigens. Immunol Rev 47:63, 1979
20. Ozato K, Mayer N, Sachs DH: Hybridoma cell lines secreting monoclonal antibodies to mouse H2 and Ia antigens. J Immunol 124:533, 1980
21. Shen FW: Monoclonal antibodies to mouse lymphocyte differentiation antigens, in Hammerling GJ, Hammerling U, Kearney JF (eds): Monoclonal Antibodies and T Cell Hybridomas: Perspectives and Technical Advances. Amsterdam, The Netherlands, Elsevier/North Holland and Biomedical Press, 1981, p 25
22. Vallera DA, Taylor PA, Sprent J, Blazar BR: The role of host T cell subsets in bone marrow rejection directed to isolated major histocompatibility complex class I versus class II differences of bm1 and bim12 mutant mice. Transplantation 57:249, 1994
23. Alexander-Miller MA, Leggatt GR, Berzofsky JA: Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy. Proc Natl Acad Sci USA 93:4102, 1996
24. Cai Z, Sprent J: Resting and activated T cells display different requirements for CD8 molecules. J Exp Med 179:2005, 1994
25. Lapidot T, Lubin I, Terenzi A, Faktorowich Y, Erlich P, Reisner Y: Enhancement of bone marrow allografts from nude mice into mismatched recipients by T cells void of graft-versus-host activity. Proc Natl Acad Sci USA 87:4595, 1990
26. Faktorowich Y, Lapidot T, Lubin I, Reisner Y: Enhancement of BM allografting from C57BL/6 'nude' mice into C3H/HeJ recipients by tolerized T cells from (C57BL/6 → C3H/HeJ) and (C3H/HeJ → C57BL/6) chimeras. Bone Marrow Transplant 12:15, 1993
27. Fink PJ, Rammensee HG, Bevan MJ: Cloned cytolytic T cells can suppress primary cytotoxic responses directed against them. J Immunol 133:1775, 1984
28. Fink PJ, Rammensee HG, Benedetto JD, Staerz UD, Lefrancois L, Bevan MJ: Studies on the mechanism of suppression of primary cytotoxic responses by cloned cytotoxic T lymphocytes. J Immunol 133:1769, 1984
29. Claesson MH, Miller RG: Functional heterogeneity in allospecific cytoxic T lymphocyte clones I. CTL clones express strong anti-self suppressive activity. J Exp Med 160:1702, 1984
30. Drobyski WR, Majewski D: Donor γδ T lymphocytes promote allogeneic engraftment across the major histocompatibility barrier in mice. Blood 89:1100, 1997
31. Fisher-Lindahl L, Wilson DB: Histocompatibility antigen-activated cytotoxic T lymphocytes. II. Estimates of the frequency and specificity of precursors. J Exp Med 145:508, 1977
32. b alloantigens are as frequent as those reactive against a whole foreign haplotype. J Immunol 124:48, 1980
33. Dailey MO, Fathman CG, Butcher EC, Pillemer E, Weissman IL: The in vivo behavior of T cell clones: Altered migration due to loss of the lymphocyte surface homing receptor. J Mol Cell Immunol 2:27, 1985
34. Dailey MO, Fathman CG, Butcher C, Pillemer E, Weissman IL: Abnormal migration of T lymphocyte clones. J Immunol 128:2134, 1982
35. Carroll AM, Palladino MA, Oettgen H, DeSousa M: In vivo localization of cloned IL-2-dependent T cells. Cell Immunol 76:69, 1983
36. LeFever AV, Truitt RL, Shih CC-Y, Liepins A, Bortin MM: Migration patterns and functional activity of cloned cytotoxic T lymphocytes in syngeneic and allogeneic mice. Transplantation 37:410, 1984
37. Rodrigues M, Nussenzweig RS, Romero P, Zavala F: The in vivo cytotoxic activity of CD8+ T cell clones correlates with their levels of expression of adhesion molecules. J Exp Med 175:895, 1992
38. Rocha B, von Boehmer H: Peripheral selection of the T cell repertoire. Science 251:1225, 1991
39. Rocha B, Grandien A, Freitas AA: Anergy and exhaustion are independent mechanisms of peripheral T cell tolerance. J Exp Med 181:993,1995
40. Zhang L, Miller RG, Zhang J: Characterization of apoptosisresistant antigen-specific T cells in vivo. J Exp Med 183:2065, 1996
41. Miconnet I, Huchet R, Bonardelle D, Motta R, Canon C, Garay-Rojas E, Kress M, Reynes M, Halle-Pannenko O, Bruley-Rosset M: Graft-versus-host mortality induced by noncytolytic CD4+ T cell clones specific for non-H2 antigens. J Immunol 145:2123, 1990
42. Lehmann PV, Schumm G, Moon D, Hurtenbach U, Falcioni F, Muller S, Nagy ZA: Acute lethal graft-versus-host reaction induced by major histocompatibility complex class II-reactive T helper cell clones. J Exp Med 171:1485, 1990